RecruitingNot ApplicableNCT06827990
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
Evaluation of the GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
Sponsor
W.L.Gore & Associates
Enrollment
112 participants
Start Date
Sep 22, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying GORE® Ascending Stent Graft (ASG device) for people with aortic dissection. The study is currently recruiting participants at 16 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEGORE® Ascending Stent Graft (ASG device)
Endovascular aortic repair of the ascending aorta
Locations(18)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06827990
Related Trials
PregnAncy-Related Aortic DISsEction in China
NCT076722104 locations
Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection
NCT069688061 location
Cardiovascular Health Improvement Project
NCT023062001 location
Valved Graft PMCF Study
NCT0475421725 locations
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
NCT047466771 location